0000899243-22-030800.txt : 20220912 0000899243-22-030800.hdr.sgml : 20220912 20220912163020 ACCESSION NUMBER: 0000899243-22-030800 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220908 FILED AS OF DATE: 20220912 DATE AS OF CHANGE: 20220912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARKISON BRIAN A CENTRAL INDEX KEY: 0001283061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36569 FILM NUMBER: 221238891 MAIL ADDRESS: STREET 1: 501 FIFTH STREET CITY: BRISTOL STATE: TN ZIP: 37620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lantheus Holdings, Inc. CENTRAL INDEX KEY: 0001521036 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 352318913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 BUSINESS PHONE: 978 671-8001 MAIL ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 FORMER COMPANY: FORMER CONFORMED NAME: Lantheus MI Holdings, Inc. DATE OF NAME CHANGE: 20110517 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-08 0 0001521036 Lantheus Holdings, Inc. LNTH 0001283061 MARKISON BRIAN A C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 1 0 0 0 Common Stock 2022-09-08 4 M 0 3263 21.13 A 53231 D Common Stock 2022-09-08 4 M 0 9464 19.11 A 62695 D Common Stock 2022-09-08 4 M 0 11725 17.06 A 74420 D Common Stock 2022-09-08 4 S 0 4172 83.045 D 70248 D Common Stock 2022-09-08 4 S 0 23852 84.1038 D 46396 D Common Stock 2022-09-08 4 S 0 13788 84.8408 D 32608 D Stock Option (right to buy) 21.13 2022-09-08 4 M 0 3263 0.00 D 2014-04-30 2023-04-30 Common Stock 3263 0 D Stock Option (right to buy) 19.11 2022-09-08 4 M 0 9464 0.00 D 2023-05-06 Common Stock 9646 0 D Stock Option (right to buy) 17.06 2022-09-08 4 M 0 11725 0.00 D 2024-01-23 Common Stock 11725 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.455 to $83.44, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.48 to $84.475, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.48 to $85.33, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. The stock options under this grant vested in equal monthly installments over the twelve months beginning on May 6, 2013. The stock options under this grant vested in equal monthly installments over the twelve months beginning on January 23, 2014. /s/ Eric M. Green, attorney-in-fact 2022-09-12